Growth Metrics

Gilead Sciences (GILD) EBIT Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -784.00
Dec 31, 2025 -1,069.00
Sep 30, 2025 1,240.00
Jun 30, 2025 9,293.00
Mar 31, 2025 -974.00
Dec 31, 2024 1,380.00
Sep 30, 2024 3,805.00
Jun 30, 2024 -472.00
Mar 31, 2024 -10,700.00
Dec 31, 2023 292.00
Sep 30, 2023 -967.00
Jun 30, 2023 -1,514.00
Mar 31, 2023 -1,547.00
Dec 31, 2022 1,933.00
Sep 30, 2022 -1,825.00
Jun 30, 2022 -2,716.00
Mar 31, 2022 -5,492.00
Dec 31, 2021 -4,228.00
Sep 30, 2021 -688.00
Jun 30, 2021 -2,223.00
Mar 31, 2021 -1,468.00
Dec 31, 2020 -3,036.00
Sep 30, 2020 -3,691.00
Jun 30, 2020 -12,612.00
Mar 31, 2020 -2,743.00
Dec 31, 2019 -4,061.00
Sep 30, 2019 -8,388.00
Jun 30, 2019 -2,477.00
Mar 31, 2019 -1,851.00
Dec 31, 2018 -1,863.00
Sep 30, 2018 563.00
Jun 30, 2018 -133.00
Mar 31, 2018 182.00
Dec 31, 2017 -3,142.00
Sep 30, 2017 1,552.00
Jun 30, 2017 1,554.00
Mar 31, 2017 2,285.00
Dec 31, 2016 1,584.00
Sep 30, 2016 1,135.00
Jun 30, 2016 1,079.00
Mar 31, 2016 1,285.00
Dec 31, 2015 2,459.00
Sep 30, 2015 1,680.00
Jun 30, 2015 1,662.00
Mar 31, 2015 1,506.00
Dec 31, 2014 678.00
Sep 30, 2014 795.00
Jun 30, 2014 2,131.00
Mar 31, 2014 806.00